Summary & Overview
CPT 89331: Urine Sperm Analysis for Retrograde Ejaculation
CPT code 89331 identifies a laboratory test that analyzes a urine specimen for the presence of sperm to determine retrograde ejaculation. This targeted diagnostic assay supports evaluation of male infertility and post-ejaculatory dysfunction and is performed by trained laboratory personnel as the technical component of testing. Nationally, accurate coding for this service matters for appropriate laboratory billing, clinical documentation, and ensuring diagnostic pathways for patients with suspected ejaculatory disorders.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for testing, typical sites of service, and payer coverage framing. The publication also summarizes common modifiers used with laboratory technical services and highlights benchmarking and reimbursement context where available.
This summary provides clinicians, billing professionals, and payers with concise guidance on the purpose of CPT code 89331, what the service represents in diagnostic workflows, and which national payers are commonly involved. Data not available in the input is noted where applicable, and the report focuses on clinical and coding clarity rather than specific treatment recommendations.
Billing Code Overview
CPT code 89331 describes a laboratory service in which a lab analyst performs the technical analysis of a urine specimen to detect and quantify sperm cells to determine whether retrograde ejaculation is occurring. This service is a diagnostic semen/urine analysis focused on identifying sperm in post-ejaculatory urine.
-
Service type: Laboratory diagnostic testing (technical component)
-
Typical site of service: Clinical laboratory or hospital laboratory performing urinary semen analysis
Clinical & Coding Specifications
Clinical Context
A 42-year-old man presents to a urology clinic with complaints of infertility after several months of unsuccessful conception attempts with his partner and symptoms of decreased ejaculate volume and occasional cloudy urine after intercourse. The urologist suspects retrograde ejaculation based on history and physical exam. The clinical workflow includes counseling the patient, obtaining informed consent, and collecting a post-ejaculatory urine specimen following masturbation or sexual intercourse in a private collection room. The specimen is transported to the laboratory where a clinical laboratory scientist or andrology technician performs a semen analysis on the urine to detect and quantify spermatozoa. Results are reviewed by the urologist to confirm retrograde ejaculation and inform subsequent management, such as medical therapy adjustment or assisted reproductive planning.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician interpretation of the test and the laboratory performs the technical component separately. |
TC | Technical component | Use when reporting only the laboratory technical performance of the test (applicable for lab performing the analysis). |